Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

Authors:

Abstract
Golimumab is a new anti-TNF-alpha monoclonal antibody for patients with ulcerative colitis.

This publication has 16 references indexed in Scilit: